Bretoni A, Ferrario L, & Foglia E. (2019). HTA and innovative treatments evaluation: The case of metastatic castration-resistant prostate cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationBretoni A, Ferrario L, and Foglia E. HTA and Innovative Treatments Evaluation: The Case of Metastatic Castration-resistant Prostate Cancer. Dove Medical Press, 2019.
MLA (9th ed.) CitationBretoni A, et al. HTA and Innovative Treatments Evaluation: The Case of Metastatic Castration-resistant Prostate Cancer. Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.